174 related articles for article (PubMed ID: 7752317)
1. Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma.
Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
J Urol; 1995 Jun; 153(6):1787-90. PubMed ID: 7752317
[TBL] [Abstract][Full Text] [Related]
2. Low level of superoxide dismutase activity in pheochromocytoma.
Nakada T; Koike H; Katayama T
J Urol; 1987 Jul; 138(1):9-13. PubMed ID: 3599227
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of telomerase activity in malignant pheochromocytoma.
Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
[TBL] [Abstract][Full Text] [Related]
4. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues.
Marklund SL; Westman NG; Lundgren E; Roos G
Cancer Res; 1982 May; 42(5):1955-61. PubMed ID: 7066906
[TBL] [Abstract][Full Text] [Related]
5. Copper- and zinc-containing superoxide dismutase and manganese-containing superoxide dismutase in human tissues and human malignant tumors.
Westman NG; Marklund SL
Cancer Res; 1981 Jul; 41(7):2962-6. PubMed ID: 7248954
[TBL] [Abstract][Full Text] [Related]
6. [Expression of mRNAs coding for catecholamine synthesizing enzymes in human adrenal pheochromocytoma].
Isobe K; Yukimasa N; Takekoshi K; Nomura F; Nakai T
Rinsho Byori; 1995 Jun; 43(6):540-4. PubMed ID: 7602797
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine metabolism in pheochromocytoma and normal adrenal medullae.
Nakada T; Furuta H; Katayama T
J Urol; 1988 Dec; 140(6):1348-51. PubMed ID: 2903937
[TBL] [Abstract][Full Text] [Related]
8. [New aspects and possibilities in the diagnosis of pheochromocytoma].
Marek J; Kopecká J; Musilová J; Horký K; Petrásek J
Cas Lek Cesk; 1989 Jul; 128(29):907-14. PubMed ID: 2790888
[TBL] [Abstract][Full Text] [Related]
9. [Morphological criteria of the malignancy of pheochromocytoma].
Cheremnykh AA; Kalashnikov SA
Arkh Patol; 1984; 46(12):30-6. PubMed ID: 6395836
[TBL] [Abstract][Full Text] [Related]
10. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
[TBL] [Abstract][Full Text] [Related]
11. Stathmin as a marker for malignancy in pheochromocytomas.
Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
[TBL] [Abstract][Full Text] [Related]
12. [Malignant pheochromocytoma. A case report and comments on a rare pathology].
Boneschi M; Erba M; Rinaldi P; Cusmai F; Miani S
Minerva Chir; 1999; 54(1-2):73-8. PubMed ID: 10230231
[TBL] [Abstract][Full Text] [Related]
13. Differential heparanase-1 expression in malignant and benign pheochromocytomas.
Quiros RM; Kim AW; Maxhimer J; Gattuso P; Xu X; Prinz RA
J Surg Res; 2002 Nov; 108(1):44-50. PubMed ID: 12443714
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in benign and malignant adrenal tumors.
Bamberger CM; Else T; Bamberger AM; Frilling A; Beil FU; Allolio B; Schulte HM
Exp Clin Endocrinol Diabetes; 1999; 107(4):272-5. PubMed ID: 10433067
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
[TBL] [Abstract][Full Text] [Related]
16. [Biological diagnosis of pheochromocytoma: impact of technological improvement].
Peyrin L; Mornex R
Ann Biol Clin (Paris); 1993; 51(10-11):835-65. PubMed ID: 8210060
[TBL] [Abstract][Full Text] [Related]
17. [Clinicomorphological aspects of adrenal pheochromocytoma diagnostics].
Khmel'nitskaia NM; Il'inskaia EV; Filippova OV
Arkh Patol; 2011; 73(5):36-40. PubMed ID: 22288171
[TBL] [Abstract][Full Text] [Related]
18. [Malignant pheochromocytoma. Personal experience, review of the literature].
De Toma G; Letizia C; Cavallaro G; Giacchino V; Mosiello G; Cavallaro A; Basile U
Ann Ital Chir; 2002; 73(4):413-8; discussion 418-9. PubMed ID: 12661231
[TBL] [Abstract][Full Text] [Related]
19. The effects of catechin on superoxide dismutase activity and its gene expression in pheochromocytoma cells.
Chow JM; Liu JC; Che YJ; Hsieh MH; Kao PF; Cheng JJ; Chan P
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):138-43. PubMed ID: 12135191
[TBL] [Abstract][Full Text] [Related]
20. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
